Company intelligence / Profile preview

Lir Analytical

Ownership: Private
Development stage: Commercial

Overview

Lir Analytical develops and manufactures innovative antimicrobial and biosecurity solutions aimed at preventing infectious diseases and combating antimicrobial resistance. Their products are used across medical, food processing, clinical, animal healthcare, veterinary, and food production industries. The company has published peer-reviewed research demonstrating the urgent need for their solutions in both human and animal health environments.

Therapeutic areas: Infectious Diseases
Modalities: Antimicrobial solutionSmall molecule (inferred, as biosecurity/antimicrobial agents are typically small molecules or chemical blends)
Industry: Non-Drug Biotech

Partnerships

Longford Local Enterprise Office (support/funding)

Beyond the preview

Go deeper on Lir Analytical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lir Analytical.

Explore the full profile